Randy Kardon
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Randy Kardon sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Randy Kardon: 4 sponsored US clinical trials, 3 recruiting.
Randy Kardon sponsors 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. The most-studied condition in this pipeline is Acute Zonal Occult Outer Retinopathy, with 1 trials.
Upper-quartile sponsor footprint
Randy Kardon sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Objectively Diagnose and Monitor Treatment of Light Sensitivity
NCT03694626
New Non-invasive Modalities for Assessing Retinal Structure and Function
NCT03475173
Smartphone Flicker Fusion Test for Patients With Optic Disorders.
NCT03475147
LSFG-SKIN, Laser Speckle Flowgraphy
NCT03660618
What is open in the Randy Kardon pipeline
3 recruiting of 4 indexed (75% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Acute Zonal Occult Outer Retinopathy (1 trial), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Randy Kardon: open-pipeline peers nationwide
Peers matched on 4 registered trials and 75% open enrollment, not the therapeutic-area sidebar.
Randy Kardon sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 75% open enrollment (± trial volume)
- Acepodia Biotech · 75% recruiting · 4 trials
- American Laboratory Products Company · 75% recruiting · 4 trials
- Amryt Pharma · 75% recruiting · 4 trials
- Amydis · 75% recruiting · 4 trials
Related
What to do with this Randy Kardon page
4 registered trials is a research-attention snapshot, not an endorsement of Randy Kardon or any single study.
- 3 of Randy Kardon's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Acute Zonal Occult Outer Retinopathy is the condition Randy Kardon studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Zonal Occult Outer Retinopathy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Randy Kardon pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.